End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study

Paul Muntner, Asghar Arshad, Stephen A Morse, Dharmendrakumar A Patel, Pronabesh D Manapatra, Efrain Reisin, Erwin A Aguilar, Wei Chen, Sathanur Srinivasan, Gerald S Berenson, Paul Muntner, Asghar Arshad, Stephen A Morse, Dharmendrakumar A Patel, Pronabesh D Manapatra, Efrain Reisin, Erwin A Aguilar, Wei Chen, Sathanur Srinivasan, Gerald S Berenson

Abstract

Background: Risk factors in childhood create a life-long burden important in the development of cardiovascular (CV) disease in adulthood. Many risk factors for CV disease (e.g., hypertension) also increase the risk of renal disease. However, the importance of childhood risk factors on the development of chronic kidney disease and end-stage renal disease (ESRD) is not well characterized.

Methods: The current observations include data from Bogalusa Heart Study participants who were examined multiple times as children between 1973 and 1988.

Results: Through 2006, fifteen study participants subsequently developed ESRD in adulthood; seven with no known overt cause. Although the Bogalusa Heart Study population is 63% white and 37% black and 51% male and 49% female, all seven ESRD cases with no known overt cause were black males (p < 0.001). Mean age-adjusted systolic and diastolic blood pressure in childhood was higher among the ESRD cases (114.5 mmHg and 70.1 mmHg, respectively) compared to black (103.0 mmHg and 62.3 mmHg, respectively) and white (mean = 103.3 mmHg and 62.3 mmHg, respectively) boys who didn't develop ESRD. The mean age-adjusted body mass index in childhood was 23.5 kg/m2 among ESRD cases and 18.6 kg/m2 and 18.9 kg/m2 among black and white boys who didn't develop ESRD, respectively. Plasma glucose in childhood was not significantly associated with ESRD.

Conclusion: These data suggest black males have an increased risk of ESRD in young adulthood. Elevated body mass index and blood pressure in childhood may increase the risk for developing ESRD as young adults.

References

    1. Meguid El NA, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365:331–340.
    1. United States Renal Data System (USRDS) USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, National Instistutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
    1. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16:3736–3741. doi: 10.1681/ASN.2005010112.
    1. Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR, Berenson GS. Inter-relationships among childhood BMI, childhood height, and adult obesity: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2004;28:10–16. doi: 10.1038/sj.ijo.0802544.
    1. Hoq S, Chen W, Srinivasan SR, Berenson GS. Childhood blood pressure predicts adult microalbuminuria in African Americans, but not in whites: the Bogalusa Heart Study. Am J Hypertens. 2002;15:1036–1041. doi: 10.1016/S0895-7061(02)03066-2.
    1. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, Berenson GS, Stein JH. Increased subclinical atherosclerosis in young adults with metabolic syndrome:the Bogalusa Heart Study. J Am Coll Cardiol. 2005;46:457–463. doi: 10.1016/j.jacc.2005.04.046.
    1. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes. 2000;49:1042–1048. doi: 10.2337/diabetes.49.6.1042.
    1. Berenson GS, McMahan C, Voors AW, Webber LS, Srinivasan SR, Frank GC. Cardiovascular risk factors in children: The early natural history of atherosclerosis and essential hypertension. New York, NY:Oxford University Press; 1980.
    1. Newman WP, Wattigney W, Berenson GS. Autopsy studies in United States children and adolescents. Relationship of risk factors to atherosclerotic lesions. Ann N Y Acad Sci. 1991;623:16–25. doi: 10.1111/j.1749-6632.1991.tb43715.x.
    1. Newman WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med. 1986;314:138–144.
    1. Tracy RE, Newman WP, Wattigney WA, Berenson GS. Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci. 1995;310(Suppl 1):S37–S41.
    1. Tracy RE, Mercante DE, Moncada A, Berenson G. Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol. 1986;85:312–318.
    1. McMahan CA, McGill HC, Gidding SS, Malcom GT, Newman WP, Tracy RE, Strong JP. PDAY risk score predicts advanced coronary artery atherosclerosis in middle-aged persons as well as youth. Atherosclerosis. 2007;190:370–377. doi: 10.1016/j.atherosclerosis.2006.02.008.
    1. Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand. 1958;44:255–272. doi: 10.1111/j.1748-1716.1958.tb01626.x.
    1. Mulvany MJ. The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension. J Hypertens. 1987;5:129–136. doi: 10.1097/00004872-198704000-00001.
    1. Brancati FL, Whelton PK, Randall B, Neaton J, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. JAMA. 1997;278:2069–2074. doi: 10.1001/jama.278.23.2069.
    1. Perneger TV, Brancati FL, Whelton PK, Klag MJ. End-stage renal disease attributable to diabetes mellitus. Annals of Internal Medicince. 1994;121:912–918.
    1. Muntner P, Coresh J, Smith JC, Eckfeldt JH, Klag MJ. Plasma lipids and a decline in renal function: The Atherosclerosis Risk in Communities Study. Kidney International. 2000;58:293–301. doi: 10.1046/j.1523-1755.2000.00165.x.
    1. Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, Levey AS. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002;57:327–335.
    1. Berenson GS, Srinivasan SR. Emergence of obesity and cardiovascular risk for coronary artery disease: the Bogalusa Heart Study. Prev Cardiol. 2001;4:116–121. doi: 10.1111/j.1520-037X.2001.00537.x.
    1. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999;150:667–674.
    1. Srinivasan SR, Bao W, Wattigney WA, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism. 1996;45:235–240. doi: 10.1016/S0026-0495(96)90060-8.
    1. Haji SA, Ulusoy RE, Patel DA, Srinivasan SR, Chen W, Delafontaine P, Berenson GS. Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study) Am J Cardiol. 2006;98:1234–1237. doi: 10.1016/j.amjcard.2006.05.054.
    1. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation. 2004;110:3488–3492. doi: 10.1161/01.CIR.0000149713.48317.27.
    1. Burke GL, Arcilla RA, Culpepper WS, Webber LS, Chiang YK, Berenson GS. Blood pressure and echocardiographic measures in children: the Bogalusa Heart Study. Circulation. 1987;75:106–114.
    1. Tracy RE, Velez-Duran M, Heigle T, Oalmann MC. Two variants of nephrosclerosis separately related to age and blood pressure. Am J Pathol. 1988;131:270–282.
    1. Voors AW, Foster TA, Frerichs RR, Webber LS, Berenson GS. Studies of blood pressures in children, ages 5-14 years, in a total biracial community: the Bogalusa Heart Study. Circulation. 1976;54:319–327.
    1. Perry H, Miller J, Fornoff J, Baty J, Sambhi M, Rutan G, Moskowitz D, Carmody S. Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients. Hypertension. 1995;25:587–594.
    1. Vupputuri S, Batuman V, Muntner P, Bazzano LA, Lefante JJ, Whelton PK, He J. Effect of blood pressure on early decline in kidney function among hypertensive men. Hypertension. 2003;42:1144–1149. doi: 10.1161/01.HYP.0000101695.56635.31.
    1. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP) J Am Soc Nephrol. 2002;13:2776–2782. doi: 10.1097/01.ASN.0000031805.09178.37.
    1. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923–928. doi: 10.1001/archinte.165.8.923.
    1. Reynolds K, Gu D, Muntner P, Kusek JW, Chen J, Wu X, Duan X, Chen CS, Klag MJ, Whelton PK, He J. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol. 2007;18:1928–1935. doi: 10.1681/ASN.2006111199.
    1. Klag MJ, Whelton P, Randall B, Neaton J, Brancati F, Ford C, Shulman N, Stamler J. Blood pressure and End-stage renal disease in men. NEJM. 1996;334:13–18. doi: 10.1056/NEJM199601043340103.
    1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79. doi: 10.1001/jama.289.1.76.
    1. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis. 2005;46:587–594. doi: 10.1053/j.ajkd.2005.06.007.
    1. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28.
    1. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–1876. doi: 10.1111/j.1523-1755.2004.00582.x.
    1. Berenson GS, Voors AW, Dalferes ER Jr, Webber LS, Shuler SE. Creatinine clearance, electrolytes, and plasma renin activity related to the blood pressure of white and black children--the Bogalusa Heart Study. J Lab Clin Med. 1979;93:535–548.
    1. Voors AW, Berenson GS, Dalferes ER, Webber LS, Shuler SE. Racial differences in blood pressure control. Science. 1979;204:1091–1094. doi: 10.1126/science.451554.
    1. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa LY, Kirk KA, Glassock R. The AASK Study Investigators. Renal histopathology in USAfrican-Americans with presumed hypertensive nephrosclerosis. Nephrology. 1998;4:S54–S58. doi: 10.1111/j.1440-1797.1998.tb00473.x.
    1. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288:1728–1732. doi: 10.1001/jama.288.14.1728.
    1. Freedman DS, Srinivasan SR, Valdez RA, Williamson DF, Berenson GS. Secular increases in relative weight and adiposity among children over two decades: the Bogalusa Heart Study. Pediatrics. 1997;99:420–426. doi: 10.1542/peds.99.3.420.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir